Brief: Altamira Therapeutics Re-Launches Bentrio In Europe For Allergic Rhinitis
27/09/2022 14:23
Sept 27 (Reuters) - Altamira Therapeutics Ltd CYTO.O :
* ALTAMIRA THERAPEUTICS RE-LAUNCHES BENTRIO IN EUROPE FOR
ALLERGIC
RHINITIS
* ALTAMIRA THERAPEUTICS LTD - PARTNERING DISCUSSIONS FOR
DISTRIBUTION IN EUROPE AND US EXPECTED TO CONCLUDE IN Q4 2022
* ALTAMIRA THERAPEUTICS LTD - BENTRIO NASAL SPRAY WILL BE
RE-LAUNCHED IN EUROPE, INITIALLY IN GERMANY, BEGINNING IN EARLY
OCTOBER OF 2022
Source text for Eikon: ID:nGNX90P5L9
Further company coverage: CYTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering